Highlights for December 2016
Sun Pharma acquires 14.58% stake in scPharmaceuticals for $13 mn
Sun Pharma to buy drug from Novartis for $175m
OSE, Servier ink $10.7M deal to develop autoimmune drug
Incyte in $200M-plus Merus research deal, shares jump
Bristol pens 'armed' early-stage cancer virus deal with U.K.’s PsiOxus
Novartis made two buys, striking a $50 million NASH licensing with microcap Conatus, and a buyout of eye drug biotech Encore Vision
Purdue inks Shionogi collab on constipation med as it awaits FDA approval
Northern Biologics merges with Mosaic Bio as Versant, Celgene boost involvement
For more such news and updates, please join our Group "Global Life Science Business Partnering" on LinkedIn